Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.

doi:10.1016/j.cgh.2024.05.052

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 1 Nov 2024

Sookoian Silvia, Rotman Yaron, Valenti Luca

Abstract excerpt

Recent advances in the genetics of metabolic dysfunction-associated steatotic liver disease (MASLD) are gradually revealing the mechanisms underlying the heterogeneity of the disease and have shown promising results in patient stratification. Genetic characterization of the disease has been rapidly developed using genome-wide association studies, exome-wide association studies, phenome-wide association studies,...

Topics

Humans
Genetic Predisposition to Disease
Fatty Liver
Genome-Wide Association Study
High-Throughput Nucleotide Sequencing

Source

Open in PubMed Open full text

Identifiers

PMID: 39094912
DOI: 10.1016/j.cgh.2024.05.052
PMCID: PMC11512675

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics